128312-78-7

Basic information

• Product Name: 1-(2-hydroxyethyl)cyclopropanol
• Synonyms: 1-(2-hydroxyethyl)cyclopropanol;1-(2-HYDROXYETHYL)CYCLOPROPAN-1-OL
• CAS NO: 128312-78-7
• Molecular Formula: C₅H₁₀O₂
• Molecular Weight: 102.1317
• Mol File: 128312-78-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 240.5±8.0 °C(Predicted)
• Appearance: /
• Density: 1.219±0.06 g/cm3(Predicted)
• PKA: 14.90±0.20(Predicted)
• CAS DataBase Reference: 1-(2-hydroxyethyl)cyclopropanol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-hydroxyethyl)cyclopropanol(128312-78-7)
• EPA Substance Registry System: 1-(2-hydroxyethyl)cyclopropanol(128312-78-7)

Safety Data

• Hazardous Substances Data: 128312-78-7(Hazardous Substances Data)

Usage

General Description

1-(2-hydroxyethyl)cyclopropanol is a chemical compound with the molecular formula C5H10O2 and a molecular weight of 102.13 g/mol. It is a colorless liquid and is classified as a cyclic alcohol. 1-(2-hydroxyethyl)cyclopropanol is used in the production of pharmaceuticals and as a solvent in organic synthesis. It is also used as a building block in the synthesis of various derivatives and specialty chemicals. 1-(2-hydroxyethyl)cyclopropanol is considered to have low toxicity and is not expected to cause significant adverse effects on human health or the environment when used according to standard safety practices.

Upstream product

• 1221443-25-9 1-[2-(tetrahydro-2H-pyran-2-yloxy)ethyl]-cyclopropanol 

Downstream Products

• 1245931-60-5 1-(2-(4-(4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamido)-2-fluorophenoxy)quinolin-7-yloxy)ethyl)cyclopropyl 2-(tert-butoxycarbonylamino)acetate 
• 1221442-86-9 N-(3-fluoro-4-(7-(2-(1-hydroxycyclopropyl)ethoxy)quinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide 
• 128312-81-2 2-(1-hydroxycyclopropyl)ethyl 4-methylbenzene-1-sulfonate 

Relevant articles and documents

GPR40 AGONISTS IN ANTI-DIABETIC DRUG COMBINATIONS

Disclosed are compositions comprising (a) a GPR40 agonist and (b) an SGLT2 inhibitor, and methods for treating of disorders that are affected by the modulation of the GPR40 receptor and SGLT2 transporter. Such GPR40 compounds are represented by Formula (I) as follows: wherein ring W, R1, R2, R3, R5, R6, A, and Z, are defined herein.

AMINO ESTER DERIVATIVES, SALTS THEREOF AND METHODS OF USE

The present invention provides amino ester compounds, salts, and pharmaceutical formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

AMINO ESTER DERIVATIVES, SAILTS THEREOF AND METHODS OF USE

The present invention provides amino ester compounds, salts, and pharmaceutical formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.